BIRC2 and melanoma: To determine whether the newly developed SMAC-mimetics caused the degradation of cIAP1 and cIAP2, we treated the four melanoma cell lines with the monomeric or dimeric SMAC-mimetics and analysed the effect of treatment on cIAP1/2 expression.